Mechanisms of growth inhibition in keratinocytes by mercurio-substituted 4',5'-dihydropsoralens.
暂无分享,去创建一个
D. Laskin | A. Vetrano | D. Heck | J. Laskin | T. Mariano | N. Heindel | C. A. Martey | Marilyn S. Whittemore | S. Gentile
[1] R. Stern. The risk of melanoma in association with long-term exposure to PUVA. , 2001, Journal of the American Academy of Dermatology.
[2] G. Stark,et al. Regulation of the G2/M transition by p53 , 2001, Oncogene.
[3] D. Coradini,et al. Sodium butyrate modulates cell cycle‐related proteins in HT29 human colonic adenocarcinoma cells , 2000, Cell proliferation.
[4] F. Gasparro,et al. Psoralen photobiology and photochemotherapy: 50 years of science and medicine. , 1999, Journal of dermatological science.
[5] B. Kamen. Folate and antifolate pharmacology. , 1997, Seminars in oncology.
[6] D. Heck,et al. Arginine metabolism in keratinocytes and macrophages during nitric oxide biosynthesis: multiple modes of action of nitric oxide synthase inhibitors. , 1997, Biochemical pharmacology.
[7] J. Vera,et al. Efficient Transport and Accumulation of Vitamin C in HL-60 Cells Depleted of Glutathione* , 1997, The Journal of Biological Chemistry.
[8] D. W. Gruenwedel,et al. Effect of Hg(II) on d(GCGCATATGCGC)2 conformation: UV absorption and circular dichroism studies. , 1993, Journal of inorganic biochemistry.
[9] D. Laskin,et al. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. , 1992, The Journal of biological chemistry.
[10] J. Laskin,et al. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment. , 1989, Molecular pharmacology.
[11] J. Laskin,et al. Characterization of a photoalkylated psoralen receptor in HeLa cells. , 1987, The Journal of biological chemistry.
[12] M. Gallo,et al. A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[13] F. Dall'acqua,et al. Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA. , 1981, Journal of medicinal chemistry.
[14] P. Song,et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY OF PSORALENS , 1979, Photochemistry and photobiology.
[15] E. Cafruny. The site and mechanism of action of mercurial diruetics. , 1968, Pharmacological reviews.
[16] G. Mudge,et al. Studies on mercurial diureis: renal excretion, acid stability and structure-activity relationships of organic mercurials. , 1962, The Journal of pharmacology and experimental therapeutics.
[17] O. Muller,et al. A polarographic study of mersalyl (salyrgan)-thiol complexes and of the excreted products of mersalyl. , 1955, The Journal of pharmacology and experimental therapeutics.
[18] J. Laskin,et al. Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic , 2004, Cancer Chemotherapy and Pharmacology.
[19] A. Vetrano,et al. Cell-impermeant pyridinium derivatives of psoralens as inhibitors of keratinocyte growth. , 2002, Biochemical pharmacology.
[20] F. Gasparro,et al. Psoralen photobiology: the relationship between DNA damage, chromatin structure, transcription, and immunogenic effects. , 1997, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[21] F. Dall'acqua,et al. Psoralen photosensitization: damages to nucleic acid and membrane lipid components. , 1996, Acta biochimica Polonica.
[22] J. Laskin,et al. Psoralen binding and inhibition of epidermal growth factor binding by psoralen/ultraviolet light (PUVA) in human epithelial cells. , 1991, Biochemical pharmacology.
[23] J. Laskin,et al. Novel syntheses of dihydroxanthyletin and dihydroseselin derivatives , 1990 .
[24] F. Dall'acqua,et al. Present aspects concerning the molecular mechanisms of photochemotherapy with psoralens. , 1986, Drugs under experimental and clinical research.
[25] Thomas B. Fitzpatrick,et al. Photochemotherapy of Skin Diseases , 1982 .
[26] John A. Parrish,et al. The Science of Photomedicine , 1982, Photobiology.